Instituto de Pesquisa Clinica Evandro Chagas CRS

Location	Oswaldo Cruz Foundation- FIOCRUZ, Avenida Brasil 4365, Manguinhos Rio de Janeiro, Brazil
Phone	55 21 25644933
CRS Coordinator	Sandra Cardoso sandra.wagner@ini.fiocruz.br 55-21-38659623
CRS Leader	Beatriz Grinsztejn beatriz.grinsztejn@gmail.com 55-21-22707064
Studies	A5243: Non-US Genomic Sampling A5354: Early ART in Acute HIV A5360: MINMON Study-Monitoring SOF/VEL in Treatment Naïve, Chronic HCV Participants A5300B:Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Participants (PHOENIx) A5332: REPRIEVE Trial A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV A5372: Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals (RPT-DTG PK Study) A5371: A Single-Arm, Open-Label, Pilot Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome with Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B